When LKB1 interacts with AMP-activated protein kinase (AMPK), it abrogates signal transduction through the mammalian target of rapamycin (mTOR) to inhibit cell growth4, thus functioning as a tumor suppressor2. Here, STK11 is linked to neoplasm.